Vatalanib Dihydrochloride CAS: 212141-51-0
MF: C20H15ClN4•2HCl
MW: 419.73
A potent inhibitor of EGFR- and RET-dependent tumor cell proliferation and survival.

Vatalanib Dihydrochloride (CAS 212141-51-0)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 118ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Vatalanib Dihydrochloride is rated 5.0 out of 5 by 1.
5
1
4
0
3
0
2
0
1
0
Alternativa namn: N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine dihydrochloride
Ansökan Vatalanib Dihydrochloride is a potent inhibitor of EGFR- and RET-dependent tumor cell proliferation and survival
Momsregistreringsnummer :: 212141-51-0
Purity: ≥96%
Molecular Weight: 419.73
Molecular Formula: C20H15ClN42HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

Vandetanib Dihydrochloride inhibits VEGFR-dependent tumor angiogenesis and EGFR- and RET-dependent tumor cell proliferation and survival. Vatalanib Dihydrochloride also inhibits Flk, c-Kit and PDGFR-β with IC50 of 270 nM, 730 nM and 580 nM, respectively. Furthermore, Vatalanib Dihydrochloride shows the anti-proliferation effect by inhibiting thymidine incorporation induced by VEGF in HUVECs


Konferenser

1. Herbst, R.S., et al. 2007. Expert Opin. Investig. Drugs. 16: 239-249. PMID: 17243944

Physical State :
Solid
Solubility :
Soluble in DMSO (30 mg/mL), ethanol (10 mg/mL) with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility.Also soluble in methanol, and water ( ≥10 mg/mL ).
LAGRING :
Store at -20° C
Melting Point :
244-246° C
IC50 :
VEGF receptor/KDR: IC50 = 37 nM; VEGF receptor/Flt-1: IC50 = 77 nM; VEGF receptor/Flk: IC50 = 270 nM; c-Kit: IC50 = 730 nM; PDGFR-β: IC50 = 580 nM; VEGF-induced phosphorylation: IC50 = 17 nM (HUVEC50s cells); VEGF-induced phosphorylation: IC50 = 34 nM (CHO cells); Thymidine incorporation induced by VEGF: IC50 = 1.7 nM (HUVEC50s)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
22386467
SMILES :
C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.Cl.Cl

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 145ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 5ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.